drugset
drugset / Trial / NCT02565134

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus

NCT02565134 ↗

Phase 2 Completed 296 enrolled Amorepacific Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is a Phase II, multi center, randomized, double-blind, placebo-controlled study in male and female subjects, aged ≥ 19 years with skin pruritus. All subjects will receive BID topical applications of PAC-14028 cream or vehicle for up to 4 weeks.

Timeline

Start
2014-10
Primary completion
2016-06
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject PAC-14028 Unknown 0.1 % Topical
Subject PAC-14028 Unknown 0.3 % Topical
Subject PAC-14028 Unknown 1 % Topical

Indications

No indication recorded.